Clinical Practice Guidelines of Cardio-Oncology
The new Clinical Practice Guidelines of Cardio-Oncology were released in August 2022. RESILIENCE is proud to count with two relevant members of the Task Force as project investigators. Teresa López-Fernández is the Chairperson of this Clinical Practice Guideline and co-Principal investigator of European Society of Cardiology (ESC) in RESILIENCE project. Raúl Córdoba is the Principal […]
What is resilience? We talked about this issue with Almudena Cid and Julio García Mera
We have had the opportunity to talk about resilience with two great figures of Spanish sports, Almudena Cid and Julio García Mera. They have shared with us how resilience has allowed them to face the most difficult moments of their sports careers and how they have transferred that resilience to their daily life. With this […]
Full house at The Science and Innovation Week
On Thursday, November 17th we participated in the XXII Week of Science and Innovation in Madrid with our activity “Visit to a CNIC laboratory to learn about the use of technology and its innovative aspects in the RESILIENCE project”. More than 60 people of different ages, students and professionals from different sectors, attended the activity […]
RESILIENCE in Portugal
On November 2nd, RESILIENCE team traveled to Portugal to visit the two medical centers that have just joined our RESILIENCE project, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO) and Hospital Da Luz. Both hospitals will collaborate in the growth of our project in the Portuguese country; IPO will identify and recruit the […]
Opening of new centers
We are glad to announce that in October 13th new centers have joined the RESILIENCE project, welcome to our team to Hospital Clínico Universitario de Valladolid! This is great news as during the summer 2022 three new sites have also been opened: • Hospital Universitario de Salamanca, July 22nd. • University of Dusseldorf (UDUS), August […]
Anthracycline-induced cardiotoxicity: what cardiologist can do about it
We were at the European Society of Cardiology Barcelona 22 congress at the end of August, where Borja Ibáñez, Director of the Clinical Research Department at Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Coordinator of the RESILIENCE project discussed the role of cardiologist on the anthracycline-induced cardiotoxicity along with Teresa López Fernández, Head […]
Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop
The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised to debate and discuss the future of Remote Ischaemic Conditioning (RIC). This evolved from the large multicentre CONDI-2–ERIC–PPCI outcome study which demonstrated no additional benefit when using RIC in the setting of […]
RESILIENCE clinical trial
Our RESILIENCE team has prepared this video in which we explain how the therapy is randomized for the RESILIENCE clinical trial. For this procedure, we will use the electronic case report form (e-CRF), a software that will assign one of the corresponding therapies randomly. The research team will access to the e-CRF via the website […]
RESILIENCE TALKS – Leaders of the Future
Interview with Alberto López-García – Fundación Jiménez Díaz University Hospital (IIS-FJD) Alberto is a young researcher leading an important part of the project. Alberto represents the young community of the project. One of the goals of RESILIENCE is to identify the European leaders of the future. Could you tell us a bit about yourself? I […]
The Quest for an Early Marker of
Anthracycline-Induced Cardiotoxicity
There is a strong need to identify (bio)markers that can detect early stages of anthracycline-induced cardiotoxicity (AIC). In this editorial, 2 RESILIENCE researchers present the current state of the art of the field. They discuss data from al original paper published in the same issue of the journal by Bonny Ky´s team, showing that paraoxonase-1 […]